Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001213900-20-015102
Filing Date
2020-06-16
Accepted
2020-06-16 16:14:54
Documents
4
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO.1 TO FORM 10-K f10k2019a1_actiniumpharma.htm 10-K/A 78675
2 DESCRIPTION OF SECURITIES f10k2019a1ex4-14_actinium.htm EX-4.14 17262
3 CERTIFICATION f10k2019a1ex31-1_actinium.htm EX-31.1 3920
4 CERTIFICATION f10k2019a1ex31-2_actinium.htm EX-31.2 3899
  Complete submission text file 0001213900-20-015102.txt   104857
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

IRS No.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36374 | Film No.: 20966638
SIC: 2834 Pharmaceutical Preparations